SI
SonoThera, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$125.5Msold at filing
Total offering$125.5M
Investors in the raise22count reported to the SEC
FiledJun 30, 2026first sale Jun 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Steven FeinsteinExecutive Officer
Kenneth GreenbergExecutive Officer, Director
Michael DavidsonExecutive Officer, Director
Rajul JainDirector
Steven GillisDirector
Rakhshita DharDirector
Carolyne ZimmermanExecutive Officer
Brian HalakDirector
Executive officers, directors and promoters as listed on the Form D.